U K
B U S I N E S S
P A R K
home page

The information below comes from the UK Activity Report.
Click here for further details

GD Searle Therapeutic Antibodies is to collaborate with GD Searle in the development of an antibody-based drug, and any future revenues will be shared between the two companies. 22-May-1998 Glaxo Wellcome and Vertex of the US are acquiring non-exclusive worldwide rights to a GD Searle patent for $25m, which will enable them to work on the 141W94 anti-HIV drug. 02-Jul-1996 The information above comes from the UK Activity Report Copyright UK Business Park 1995-2007